Body Size in Relation to Urinary Estrogens and Estrogen Metabolites (EM) Among Premenopausal Women during the Luteal Phase

Hormones and Cancer

Volumn 3, Issue 5-6, 2012, Pages 249-260

  Xie, Jing ^a,b   Eliassen, A Heather ^a,b   Xu, Xia ^c   Matthews, Charles E ^d   Hankinson, Susan E ^a,b,e   Ziegler, Regina G ^d   Tworoger, Shelley S ^a,b  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

^b HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^c SAIC FREDERICK INC   (United States)

^d NATIONAL CANCER INSTITUTE   (United States)

^e UNIVERSITY OF MASSACHUSETTS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CATECHOL; ESTROGEN;

ADULT; ARTICLE; BODY HEIGHT; BODY MASS; BODY SIZE; ESTROGEN METABOLISM; ESTROGEN URINE LEVEL; FEMALE; HUMAN; LUTEAL PHASE; METABOLITE; PREMENOPAUSE; PRIORITY JOURNAL; URINALYSIS;

EID: 84869088052     PISSN: 18688497     EISSN: 18688500     Source Type: Journal    
DOI: 10.1007/s12672-012-0120-z     Document Type: Article

References (47)

1. Baird DD, Robert McConnaughey D, Weinberg CR, Musey PI, Collins DC, Kesner JS, Knecht EA, Wilcox AJ (1995) Application of a method for estimating day of ovulation using urinary estrogen and progesterone metabolites. Epidemiology 6(5): 547-550.
2. Bentz AT, Schneider CM, Westerlind KC (2005) The relationship between physical activity and 2-hydroxyestrone, 16α-hydroxyestrone, and the 2/16 ratio in premenopausal women (United States). Cancer Causes Control 16(4): 455-461. doi: 10. 1007/s10552-004-6256-6.
3. Bonferroni CE (1936) Teoria statistica delle classi e calcolo delle probabilità. Pubblicazioni del R Istituto Superiore di Scienze Economiche e Commerciali di Firenze 8: 3-62.
4. Bradlow HL, Davis DL, Lin G, Sepkovic D, Tiwari R (1995) Effects of pesticides on the ratio of 16α/2-hydroxyestrone: a biologic marker of breast cancer risk. Environ Heal Perspect 103(Suppl 7): 147-150.
5. Bradlow HL, Hershcopf RJ, Martucci CP, Fishman J (1985) Estradiol 16 alpha-hydroxylation in the mouse correlates with mammary tumor incidence and presence of murine mammary tumor virus: a possible model for the hormonal etiology of breast cancer in humans. Proc Natl Acad Sci U S A 82(18): 6295-6299.
6. Cavalieri E, Frenkel K, Liehr JG, Rogan E, Roy D (2000) Chapter 4: Estrogens as endogenous genotoxic agents-DNA adducts and mutations. JNCI Monogr 2000(27): 75-94.
7. De Pergola G, Giorgino F, Cospite MR, Giagulli VA, Cignarell M, Ferri G, Giorgino R (1993) Relation between sex hormones and serum lipoprotein and lipoprotein(a) concentrations in premenopausal obese women. Arterioscler Thromb 13(5): 675-679.
8. Dunaif A, Mandeli J, Fluhr H, Dobrjansky A (1988) The impact of obesity and chronic hyperinsulinemia on gonadotropin release and gonadal steroid secretion in the polycystic ovary syndrome. J Clin Endocrinol Metab 66: 131-139.
9. Eliassen AH, Missmer SA, Tworoger SS, Spiegelman D, Barbieri RL, Dowsett M, Hankinson SE (2006) Endogenous steroid hormone concentrations and risk of breast cancer among premenopausal women. J Natl Cancer Inst 98(19): 1406-1415. doi: 10. 1093/jnci/djj376.
10. Eliassen AH, Spiegelman D, Xia X, Keefer LK, Veenstra TD, Barbieri RL, Willett WC, Hankinson SE, Ziegler RG (2012) Urinary estrogens and estrogen metabolites and subsequent risk of breast cancer among premenopausal women. Cancer Res 72(3): 696-706. doi: 10. 1158/0008-5472. can-11-2507.
11. Eliassen AH, Ziegler RG, Rosner B, Veenstra TD, Roman JM, Xia X, Hankinson SE (2009) Reproducibility of fifteen urinary estrogens and estrogen metabolites over a 2- to 3-year period in premenopausal women. Cancer Epidemiol Biomarkers Prev 18(11): 2860-2868. doi: 10. 1158/1055-9965. epi-09-0591.
12. The Endogenous Hormones Breast Cancer Collaborative Group (2002) Endogenous sex hormones and breast cancer in postmenopausal women: reanalysis of nine prospective studies. J Natl Cancer Inst 94(8): 606-616. doi: 10. 1093/jnci/94. 8. 606.
13. Falk RT, Xia X, Keefer L, Veenstra TD, Ziegler RG (2008) A liquid chromatography-mass spectrometry method for the simultaneous measurement of 15 urinary estrogens and estrogen metabolites: assay reproducibility and interindividual variability. Cancer Epidemiol Biomarkers Prev 17(12): 3411-3418. doi: 10. 1158/1055-9965. epi-08-0355.
14. Fishman J, Boyar RM, Hellman L (1975) Influence of body weight on estradiol metabolism in young women. J Clin Endocrinol Metab 41(5): 989-991.
15. Flötotto T, Djahansouzi S, Gläser M, Hanstein B, Niederacher D, Brumm C, Beckmann MW (2001) Hormones and hormone antagonists: mechanisms of action in carcinogenesis of endometrial and breast cancer. Horm Metab Res 33(08): 451-457. doi: 10. 1055/s-2001-16936.
16. Fortner RT, Hankinson SE, Schairer C, Xia X, Ziegler RG, Heather Eliassen A (2012) Association between reproductive factors and urinary estrogens and estrogen metabolites in premenopausal women. Cancer Epidemiol Biomarkers Prev. doi: 10. 1158/1055-9965. epi-12-0171.
17. Green J, Cairns BJ, Delphine Casabonne F, Wright L, Reeves G, Beral V (2011) Height and cancer incidence in the Million Women Study: prospective cohort, and meta-analysis of prospective studies of height and total cancer risk. Lancet Oncol 12(8): 785-794. doi: 10. 1016/s1470-2045(11)70154-1.
18. Grenman S, Ronnemaa T, Irjala K, Kaihola HL, Gronroos M (1986) Sex steroid, gonadotropin, cortisol, and prolactin levels in healthy, massively obese women: correlation with abdominal fat cell size and effect of weight reduction. J Clin Endocrinol Metab 63(6): 1257-1261. doi: 10. 1210/jcem-63-6-1257.
19. Helzlsouer KJ, Alberg AJ, Bush TL, Longcope C, Gordon GB, Comstock GW (1994) A prospective study of endogenous hormones and breast cancer. Cancer Detect Prev 18(2): 79-85.
20. Huang Z, Hankinson SE, Colditz GA, Stampfer MJ, Hunter DJ, Manson JAE, Hennekens CH, Rosner B, Speizer FE, Willett WC (1997) Dual effects of weight and weight gain on breast cancer risk. JAMA: J Am Med Assoc 278(17): 1407-1411. doi: 10. 1001/jama. 1997. 03550170037029.
21. Jozan S, Moure C, Gillois M, Bayard F (1979) Effects of estrone on cell proliferation of a human breast cancer (MCF-7) in long term tissue culture. J Steroid Biochem 10(3): 341-342.
22. Kaaks R, Rinaldi S, Key TJ, Berrino F, Peeters PHM, Biessy C, Dossus L et al (2005) Postmenopausal serum androgens, oestrogens and breast cancer risk: the European prospective investigation into cancer and nutrition. Endocr Relat Cancer 12(4): 1071-1082. doi: 10. 1677/erc. 1. 01038.
23. Kaaks R, Berrino F, Key T, Rinaldi S, Dossus L, Biessy C, Secreto G et al (2005) Serum sex steroids in premenopausal women and breast cancer risk within the European Prospective Investigation into Cancer and Nutrition (EPIC). J Natl Cancer Inst 97(10): 755-765. doi: 10. 1093/jnci/dji132.
24. Kabat GC, O'Leary ES, Gammon MD, Sepkovic DW, Teitelbaum SL, Britton JA, Terry MB, Neugut AI, Leon Bradlow H (2006) Estrogen metabolism and breast cancer. Epidemiology 17(1): 80-88.
25. Kabuto M, Akiba S, Stevens RG, Neriishi K, Land CE (2000) A prospective study of estradiol and breast cancer in Japanese women. Cancer Epidemiol Biomarkers Prev 9(6): 575-579.
26. Lippman M, Monaco ME, Bolan G (1977) Effects of estrone, estradiol, and estriol on hormone-responsive human breast cancer in long-term tissue culture. Cancer Res 37(6): 1901-1907.
27. Micheli A, Muti P, Secreto G, Krogh V, Meneghini E, Venturelli E, Sieri S, Pala V, Berrino F (2004) Endogenous sex hormones and subsequent breast cancer in premenopausal women. Int J Cancer 112(2): 312-318. doi: 10. 1002/ijc. 20403.
28. Missmer SA, Heather Eliassen A, Barbieri RL, Hankinson SE (2004) Endogenous estrogen, androgen, and progesterone concentrations and breast cancer risk among postmenopausal women. J Natl Cancer Inst 96(24): 1856-1865. doi: 10. 1093/jnci/djh336.
29. Potischman N, Swanson CA, Siiteri P, Hoover RN (1996) Reversal of relation between body mass and endogenous estrogen concentrations with menopausal status. J Natl Cancer Inst 88(11): 756-758. doi: 10. 1093/jnci/88. 11. 756.
30. Rimm EB, Stampfer MJ, Colditz GA, Chute CG, Litin LB, Willett WC (1990) Validity of self-reported waist and hip circumferences in men and women. Epidemiology 1(6): 466-473.
31. Rosenberg CR, Pasternack BS, Shore RE, Koenig KL, Toniolo PG (1994) Premenopausal estradiol levels and the risk of breast cancer: a new method of controlling for day of the menstrual cycle. Am J Epidemiol 140(6): 518-525.
32. Rosner B (1983) Percentage points for a generalized ESD many-outlier procedure. Technometrics 25(2): 165-172.
33. Schernhammer ES, Rosner B, Willett WC, Laden F, Colditz GA, Hankinson SE (2004) Epidemiology of urinary melatonin in women and its relation to other hormones and night work. Cancer Epidemiol Biomarkers Prev 13(6): 936-943.
34. Schneider J, Bradlow HL, Strain G, Levin J, Anderson K, Fishman J (1983) Effects of obesity on estradiol metabolism: decreased formation of nonuterotropic metabolites. J Clin Endocrinol Metab 56(5): 973-978.
35. Telang NT, Suto A, Wong GY, Osborne MP, Leon Bradlow H (1992) Induction by estrogen metabolite 16α-hydroxyestrone of genotoxic damage and aberrant proliferation in mouse mammary epithelial cells. J Natl Cancer Inst 84(8): 634-638. doi: 10. 1093/jnci/84. 8. 634.
36. Thomas HV, Key TJ, Allen DS, Moore JW, Dowsett M, Fentiman IS, Wang DY (1997) A prospective study of endogenous serum hormone concentrations and breast cancer risk in premenopausal women on the island of Guernsey. Br J Cancer 75(7): 1075-1079.
37. Troy LM, Hunter DJ, Manson JE, Colditz GA, Stampfer MJ, Willett WC (1995) The validity of recalled weight among younger women. Int J Obes Relat Metab Disord 19(8): 570-572.
38. Tworoger SS, Sluss P, Hankinson SE (2006) Association between plasma prolactin concentrations and risk of breast cancer among predominately premenopausal women. Cancer Res 66(4): 2476-2482. doi: 10. 1158/0008-5472. can-05-3369.
39. Tworoger SS, Heather Eliassen A, Missmer SA, Baer H, Rich-Edwards J, Michels KB, Barbieri RL, Dowsett M, Hankinson SE (2006) Birthweight and body size throughout life in relation to sex hormones and prolactin concentrations in premenopausal women. Cancer Epidemiol Biomarkers Prev 15(12): 2494-2501. doi: 10. 1158/1055-9965. epi-06-0671.
40. van den Brandt PA, Spiegelman D, Yaun S-S, Adami H-O, Beeson L, Folsom AR, Fraser G et al (2000) Pooled analysis of prospective cohort studies on height, weight, and breast cancer risk. Am J Epidemiol 152(6): 514-527. doi: 10. 1093/aje/152. 6. 514.
41. Xu X, Veenstra TD, Fox SD, Roman JM, Issaq HJ, Falk R, Saavedra JE, Keefer LK, Ziegler RG (2005) Measuring fifteen endogenous estrogens simultaneously in human urine by high-performance liquid chromatography-mass spectrometry. Anal Chem 77(20): 6646-6654. doi: 10. 1021/ac050697c.
42. Yager JD (2000) Chapter 3: Endogenous estrogens as carcinogens through metabolic activation. JNCI Monogr 2000(27): 67-73.
43. Yager JD, Davidson NE (2006) Estrogen carcinogenesis in breast cancer. N Engl J Med 354(3): 270-282. doi: 10. 1056/NEJMra050776.
44. Zeleniuch-Jacquotte A, Shore RE, Koenig KL, Akhmedkhanov A, Afanasyeva Y, Kato I, Kim MY, Rinaldi S, Kaaks R, Toniolo P (2004) Postmenopausal levels of oestrogen, androgen, and SHBG and breast cancer: long-term results of a prospective study. Br J Cancer 90(1): 153-159.
45. Zhu BT, Conney AH (1998) Functional role of estrogen metabolism in target cells: review and perspectives. Carcinogenesis 19(1): 1-27. doi: 10. 1093/carcin/19. 1. 1.
46. Ziegler RG (1997) Anthropometry and breast cancer. J Nutr 127(5): 924S-928S.
47. Zumoff B (1982) Relationship of obesity to blood estrogens. Cancer Res 42(8 Suppl): 3289s-3294s.